Listed

IGC Pharma, Inc.: Form 10-Q for the period ended Dec 31, 2011

Filed with the SEC on Feb 16, 2012 and accepted by EDGAR at Feb 16, 2012, 08:08 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2011-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2011-10-01 to 2011-12-31$986.8kus-gaap:Revenues
Revenue9 months2011-04-01 to 2011-12-31$3.0mus-gaap:Revenues
Cost of revenue3 months2011-10-01 to 2011-12-31$1.0mus-gaap:CostOfRevenue
Cost of revenue9 months2011-04-01 to 2011-12-31$2.9mus-gaap:CostOfRevenue
Selling, general and administrative3 months2011-10-01 to 2011-12-31$968.9kus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2011-04-01 to 2011-12-31$2.4mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2011-10-01 to 2011-12-31−$1.0mus-gaap:OperatingIncomeLoss
Operating income9 months2011-04-01 to 2011-12-31−$2.5mus-gaap:OperatingIncomeLoss
Interest expense3 months2011-10-01 to 2011-12-31$174.4kus-gaap:InterestExpense
Interest expense9 months2011-04-01 to 2011-12-31$624.1kus-gaap:InterestExpense
Net income3 months2011-10-01 to 2011-12-31−$1.9mus-gaap:NetIncomeLoss
Net income9 months2011-04-01 to 2011-12-31−$3.6mus-gaap:NetIncomeLoss
Operating cash flow9 months2011-04-01 to 2011-12-31−$1.2mus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2011-12-31$4.4mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2011-12-31$14.6mus-gaap:AssetsCurrent
Total assetsAt period end2011-12-31$35.1mus-gaap:Assets
Current liabilitiesAt period end2011-12-31$13.0mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2011-12-31$17.9mus-gaap:Liabilities
Short-term borrowingsAt period end2011-12-31$764.9kus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2011-12-31$13.0mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001185185-12-000256. Last ingested by Listed: Nov 6, 2026, 16:27 ET. Listed shows no prices and gives no investment advice.